Research Foci

My research interests are pedagogically and clinically-oriented. Within an academic setting, I am most interested in evaluating the cultural influences on pharmacy student clinical and social behaviors. My didactic and experiential students are a diverse representation of a new generation of learners in pharmacy education. My investigations will aim to focus on students’ prior experiences and how those events correspondingly influence behaviors and attitudes both within and outside the pharmacy classroom.

My clinical research is focused on medication reconciliation efforts in alternative transitions of care models. Pharmacist integration into transitions of care and medication reconciliation are well-published; however, there is less evidence describing the opportunities and outcomes associated with these services in non-traditional environments (e.g. pulmonary rehabilitation and bariatric surgery). My goals are to not only describe how pharmacy services are integrated into those settings, but also their impact on patient-centered care.

Publications

Boylan PM, Eltaki SA. Post-graduate year two transitions of care pharmacy residencies no longer accredited. Curr Pharm Teach Learn. [accepted for publication]

Boylan PM, Joseph T, Hale GM, Moreau C, Seamon M, Jones R. Development of chronic obstructive pulmonary disease and heart failure self-management kits for outpatient transitions of care. Consult Pharm. [accepted for publication].

Poster Presentations

Boylan P, Trinh K, Helms J, Ghoubrial-Waibel R, Mege J. Integration of transitions of care pharmacist services within an accredited pulmonary rehabilitation clinic. American College of Clinical Pharmacy Annual Meeting 2017; Phoenix, AZ. Oct 2017.

Boylan P, Eltaki S, Kearson M, Camejo M. Development of transitions of care pharmacist services for high-risk medical patients in a tertiary community hospital discharge unit. American Society of Health-System Pharmacist’s Midyear Clinical Meeting 2016; Las Vegas, NV. Dec 2016.

Boylan P, Cofsky R. Incidence of acute kidney injury in patients receiving intravenous vancomycin in combination with piperacillin-tazobactam or cefepime. American College of Clinical Pharmacy Annual Meeting 2016; Hollywood, FL. Oct 2016.

Boylan P, Cofsky R. Incidence of acute kidney injury in patients receiving intravenous vancomycin in combination with piperacillin-tazobactam or cefepime. American Society of Health-System Pharmacist’s Midyear Clinical Meeting 2015; New Orleans, LA. Dec 2015.